GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » EPS without NRI

CellSource Co (TSE:4880) EPS without NRI : 円42.55 (TTM As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co EPS without NRI?

CellSource Co's earnings per share without non-recurring items for the three months ended in Jan. 2024 was 円6.98. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2024 was 円42.55.

During the past 12 months, CellSource Co's average earnings per share (NRI) Growth Rate was -24.50% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 47.90% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 34.20% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for CellSource Co's EPS without NRI or its related term are showing as below:

TSE:4880' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 30.5   Med: 39.8   Max: 51.7
Current: 47.9

During the past 7 years, CellSource Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 51.70% per year. The lowest was 30.50% per year. And the median was 39.80% per year.

TSE:4880's 3-Year EPS without NRI Growth Rate is ranked better than
90.99% of 1298 companies
in the Biotechnology industry
Industry Median: 5.45 vs TSE:4880: 47.90

CellSource Co's EPS (Diluted) for the three months ended in Jan. 2024 was 円7.23. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was 円43.92.

CellSource Co's EPS (Basic) for the three months ended in Jan. 2024 was 円7.27. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was 円44.59.


CellSource Co EPS without NRI Historical Data

The historical data trend for CellSource Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co EPS without NRI Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EPS without NRI
Get a 7-Day Free Trial 15.29 14.33 34.10 53.41 46.36

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.07 10.06 12.61 12.90 6.98

Competitive Comparison of CellSource Co's EPS without NRI

For the Biotechnology subindustry, CellSource Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSource Co's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where CellSource Co's PE Ratio without NRI falls into.



CellSource Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円42.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellSource Co  (TSE:4880) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


CellSource Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of CellSource Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines